CHEK2 rs4822983 CC carriers showed a marginally significantly decreased ESCC risk compared with those carrying the CT and TT genotypes in the validation set (95% CI = 0.61–1.01, P = 0.064). Here, CHEK2 is linked to esophageal squamous cell carcinoma.